Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 11, 2018
Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon
Copenhagen, Denmark, April 11, 2018 - Zealand Pharma ("Zealand") reports that it has engaged in a collaboration with Roche Diabetes Care, a global leader in ...
April 11, 2018
Zogenix to Participate in LEERINK Partners CNS Day
EMERYVILLE, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
April 11, 2018
Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares
JERUSALEM, April 11, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of 6.75 million of ...
April 11, 2018
Keryx Biopharmaceuticals Receives 2018 Corporate Innovator Award from the National Kidney Foundation
AUSTIN, Texas, April 11, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, ...
April 10, 2018
Onxeo to Present Corporate Overview at the H.C. Wainwright Annual Global Life Sciences Conference
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, in particular against ...
April 10, 2018
MannKind Announces Completion of Previously Announced $28.0 Million Registered Direct Offering
WESTLAKE VILLAGE, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced the completion of its previously announced registered direct offering of 14,000,000 ...
April 10, 2018
ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology
LEIDEN, the Netherlands, April 10, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
April 10, 2018
VBL Therapeutics to Present Late-Breaking Research at the American Association for Cancer Research (AACR) 2018 Annual Meeting on April 16
TEL AVIV, Israel, April 10, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
April 10, 2018
Achaogen Announces Multiple Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
SOUTH SAN FRANCISCO, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
April 10, 2018
Spring Bank Announces Expanded Inarigivir Data from the ACHIEVE Trial to Be Presented at The International Liver Congress™
HOPKINTON, Mass., April 10, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
April 9, 2018
Arcturus Therapeutics Issues Statement Regarding Timing of Extraordinary General Meeting of Shareholders
SAN DIEGO, April 08, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that upon the recommendation of the ...
April 9, 2018
INNATE PHARMA : Upcoming investor conferences
Marseille, France, April 9, 2018, 7:00 AM CEST Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be ...
April 9, 2018
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Canada by Avir Pharma
Basel, Switzerland, April 09, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that its partner Avir Pharma Inc. ("Avir Pharma") has launched Basilea's hospital antibiotic ...
April 9, 2018
CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich
MONMOUTH JUNCTION, N.J., April 9, 2018 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in ...
April 9, 2018
ABIVAX Strengthens Its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs
PARIS--(BUSINESS WIRE)--Regulatory News: ABIVAX (ABVX.PA) (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments ...
April 9, 2018
Auris Medical Announces Early Repayment of Part of its Loan Facility
Zug, Switzerland, April 9, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
April 9, 2018
Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and ...
April 9, 2018
Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development of novel medicines to treat liver ...
April 9, 2018
VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority
TEL AVIV, Israel, April 09, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today announced that it has been awarded a grant of 8.9 million New ...
April 9, 2018
TRACON Pharmaceuticals Announces Closing of Previously Announced Private Placement and Appointment of Ted Wang, Ph.D., of Puissance Capital Management, to Board of Directors
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
Page 72 of 138